Regenxbio Inc (RGNX)
8.79
0.00 (0.00%)
USD |
NASDAQ |
Nov 04, 12:56
Regenxbio Price to Book Value: 1.247 for Nov. 4, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 01, 2024 | 1.247 |
| October 31, 2024 | 1.219 |
| October 30, 2024 | 1.254 |
| October 29, 2024 | 1.286 |
| October 28, 2024 | 1.331 |
| October 25, 2024 | 1.327 |
| October 24, 2024 | 1.360 |
| October 23, 2024 | 1.382 |
| October 22, 2024 | 1.361 |
| October 21, 2024 | 1.472 |
| October 18, 2024 | 1.575 |
| October 17, 2024 | 1.504 |
| October 16, 2024 | 1.526 |
| October 15, 2024 | 1.462 |
| October 14, 2024 | 1.448 |
| October 11, 2024 | 1.404 |
| October 10, 2024 | 1.318 |
| October 09, 2024 | 1.311 |
| October 08, 2024 | 1.357 |
| October 07, 2024 | 1.351 |
| October 04, 2024 | 1.379 |
| October 03, 2024 | 1.327 |
| October 02, 2024 | 1.408 |
| October 01, 2024 | 1.449 |
| September 30, 2024 | 1.489 |
| Date | Value |
|---|---|
| September 27, 2024 | 1.533 |
| September 26, 2024 | 1.516 |
| September 25, 2024 | 1.537 |
| September 24, 2024 | 1.591 |
| September 23, 2024 | 1.656 |
| September 20, 2024 | 1.659 |
| September 19, 2024 | 1.774 |
| September 18, 2024 | 1.778 |
| September 17, 2024 | 1.838 |
| September 16, 2024 | 1.808 |
| September 13, 2024 | 1.822 |
| September 12, 2024 | 1.728 |
| September 11, 2024 | 1.804 |
| September 10, 2024 | 1.673 |
| September 09, 2024 | 1.618 |
| September 06, 2024 | 1.629 |
| September 05, 2024 | 1.615 |
| September 04, 2024 | 1.601 |
| September 03, 2024 | 1.609 |
| August 30, 2024 | 1.734 |
| August 29, 2024 | 1.703 |
| August 28, 2024 | 1.669 |
| August 27, 2024 | 1.648 |
| August 26, 2024 | 1.719 |
| August 23, 2024 | 1.721 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.210
Minimum
May 24 2022
5.603
Maximum
Jan 14 2021
2.499
Average
2.248
Median
Mar 12 2020
Price to Book Value Benchmarks
| Sarepta Therapeutics Inc | 10.91 |
| Catalyst Pharmaceuticals Inc | 4.267 |
| Vertex Pharmaceuticals Inc | 8.229 |
| Edgewise Therapeutics Inc | 6.246 |
| Entrada Therapeutics Inc | 1.527 |
Price to Book Value Related Metrics
| PS Ratio | 4.548 |
| Price | 8.79 |
| Earnings Yield | -59.84% |
| Market Cap | 434.43M |